Halozyme Therapeutics, Inc.

RV7.F·Frankfurt·Healthcare

Compare

110.45−0.85 (−0.76%)today

As of Oct 22, 8:05 AM CEST · May be delayed up to 15 min · EUR

Key statistics

Previous close111.30

Open110.45

Day range—

52-week range52.50110.45

Off day high0.00%

Off 52-week high0.00%

Volume13.00

Avg. volume (3M)95.00

Market cap12.54B

EPS (TTM)2.93

Forward P/E42.16

P/E ratio (TTM)37.70

Dividend yield—

Beta (5Y)0.88

Shares outstanding113.50M

Short interest—

Earnings dateAug 6, 2026

Analyst target—

Profit margin24.86%

Against its peers

Compare in full ›

	RV7.F	BMRN	LGND	REGN	URGN	ROIV
Market cap	12.54B	10.69B	6.28B	82.95B	1.73B	26.58B
P/E (TTM)	37.7	149.2	33.2	19.9	—	—
Forward P/E	42.2	8.6	26.3	12.9	13.7	-21.4
Price/book	98.5	1.7	6.5	2.5	-13.1	6.3
Dividend yield	—	—	—	0.47%	—	—
1-year change	+90.37%	+1.21%	+69.63%	+39.95%	+100.91%	+104.90%
Today	−0.76%	−2.18%	+2.73%	−0.22%	+1.34%	+5.38%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Halozyme Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
BioMarin Pharmaceutical Inc.BMRN · Biotechnology	10.69B	55.21	−2.18%
Ligand Pharmaceuticals IncorporatedLGND · Biotechnology	6.28B	314.78	+2.73%
Regeneron Pharmaceuticals, Inc.REGN · Biotechnology	82.95B	805.67	−0.22%
UroGen Pharma Ltd.URGN · Biotechnology	1.73B	35.48	+1.34%
Roivant Sciences Ltd.ROIV · Biotechnology	26.58B	36.80	+5.38%
RemeGen Co., Ltd.9995.HK · Biotechnology	37.47B	62.900	−5.98%
Ultragenyx Pharmaceutical Inc.RARE · Biotechnology	1.57B	15.92	−0.62%
Telix Pharmaceuticals LimitedTLX · Biotechnology	3.41B	10.03	−10.13%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Summit Therapeutics Inc.SMMT · Miami, FL Odds	12.63B	15.83	−1.62%
BridgeBio Pharma, Inc.BBIO · Palo Alto, CA	13.24B	67.74	+0.28%
Everest Medicines Limited1952.HK · Shanghai, China	12.02B	33.980	−5.77%
Corcept Therapeutics IncorporatedCORT · Redwood City, CA	12.57B	116.28	−0.15%
Jazz Pharmaceuticals plcJAZZ · Dublin, Ireland	13.76B	211.97	−0.84%
AnGes, Inc.4563.T · Ibaraki, Japan	11.57B	29.00	−3.33%
Ascentage Pharma Group International6855.HK · Suzhou, China	10.71B	28.680	−8.25%
Bio-Techne CorporationTECH · Minneapolis, MN	11.39B	72.64	+0.08%

Healthcare companies of a similar market value (12.54B).

Company	Mkt cap	Price	Today
Summit Therapeutics Inc.SMMT · Biotechnology Odds	12.63B	15.83	−1.62%
Encompass Health CorporationEHC · Medical Care Facilities	11.88B	120.47	−0.99%
Penumbra, Inc.PEN · Medical Devices	12.74B	323.56	−0.24%
Ramsay Health Care LimitedRHC.AX · Medical Care Facilities	12.67B	54.90	+1.20%
Ipsen S.A.IPN.PA · Drug Manufacturers - Specialty & Generic	12.54B	152.20	+0.20%
Ping An Healthcare and Technology Company Limited1833.HK · Health Information Services	11.82B	5.560	−4.06%
BridgeBio Pharma, Inc.BBIO · Biotechnology	13.24B	67.74	+0.28%
ICON Public Limited CompanyICLR · Diagnostics & Research	14.29B	185.25	+6.35%

Also based in San Diego, California, then elsewhere in California.

Company	Mkt cap	Price	Today
QUALCOMM IncorporatedQCOM · San Diego, CA Odds	190.03B	177.96	+1.28%
Illumina, Inc.ILMN · San Diego, CA	42.71B	282.86	+5.57%
Realty Income CorporationO · San Diego, CA	52.37B	55.35	−1.76%
SempraSRE · San Diego, CA	54.60B	83.50	+0.83%
ResMed Inc.RMD · San Diego, CA	34.63B	246.20	+0.29%
DexCom, Inc.DXCM · San Diego, CA	30.29B	80.26	−6.39%
LPL Financial Holdings Inc.LPLA · San Diego, CA Odds	25.28B	321.03	−0.26%
Neurocrine Biosciences, Inc.NBIX · San Diego, CA	14.36B	141.31	−0.49%

Companies that serve the same markets: healthcare, life sciences.

Company	Mkt cap	Price	Today
Ascendis Pharma A/SASND · life sciences · healthcare	15.72B	238.90	+1.95%
CSL LimitedCSL.AX · life sciences · healthcare	94.12B	196.14	+0.03%
BeOne Medicines AG6160.HK · life sciences · healthcare	331.89B	224.400	−3.03%
Clinuvel Pharmaceuticals LimitedCUVL · life sciences · healthcare	258.49M	5.12	−1.35%
Hansa Biopharma AB (publ)HNSA.ST · life sciences · healthcare	3.67B	36.76	−2.23%
Aurinia Pharmaceuticals Inc.AUPH · life sciences · healthcare	2.25B	16.90	+0.96%
Ultragenyx Pharmaceutical Inc.UP0.F · life sciences · healthcare	1.38B	13.97	−1.20%
Corcept Therapeutics IncorporatedCORT · life sciences · healthcare	12.57B	116.28	−0.15%

What visitors to Halozyme Therapeutics's page also look at.

Company	Mkt cap	Price	Today
NEUROCRINE BIOSCIENCES INC.NB3.F	12.78B	125.70	+4.32%
Ultragenyx Pharmaceutical Inc.RUP0.F	1.38B	13.97	−1.20%
Arrowhead Pharmaceuticals Inc.RHDP1.F	7.31B	51.72	−1.34%
UNITED THERAPEUTICS CORP.(DEL.RUTH.F	21.30B	496.70	+1.33%
Jazz Pharmaceuticals PLCJ7Z.F	11.90B	183.30	−2.47%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All RV7.F news ›

Defense World·4d agoNegative

Halozyme Therapeutics, Inc. $HALO Stock Position Cut by First Citizens Bank & Trust Co.

Posted by Defense World Staff on Oct 18th, 2026 Here are the key news stories impacting Halozyme Therapeutics this week: View Our Latest Report on HALO Halozyme licenses its technology to pharmaceutical and biotechnology companies, which…

CNBC·6d ago

Inside Edge’s Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance

CNBC Inside Edgeâs Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance

Markets Daily·Oct 14Positive

Halozyme Therapeutics (NASDAQ:HALO) Stock Price Up 5.9% After Analyst Upgrade

Posted by Sarita Garza on Oct 14th, 2026 View Our Latest Stock Report on Halozyme Therapeutics The company has a quick ratio of 2.31, a current ratio of 2.71 and a debt-to-equity ratio of 13.50. The business has a 50-day moving average…

From articles in the 4Search news index.

In the news

7mentions in 30 days

7with it in the headline

Positivesentiment

Most coverage from

stocktitan.net2
cnbc.com1
defenseworld.net1
marketscreener.com1
themarketsdaily.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

About

Profile ›

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.

From Wikipedia, CC BY-SA 4.0

SectorHealthcare

IndustryBiotechnology

Chief executiveHelen I. Torley M.B. Ch. B., M.R.C.P.

Employees423

HeadquartersSan Diego, CA, United States

Websitehalozyme.com

Earnings

Reported EPS
Estimate

Next report: Thu, Aug 6, 2026

Quarterly results

Financials ›

Revenue
Net income
Net margin 47.8% (Q2 '26)

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.